Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1981-05-27
1984-04-17
Hazel, Blondel
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
424 88, 260112R, A61K 39095, C07C10352
Patent
active
044434316
ABSTRACT:
A vaccine affording protection against attachment of Neisseria gonorrhoeae (N.g.) to human cells, and consequent infection, is prepared from a fragment of pili protein isolated from gonococci. This fragment contains the shared antigens between pili from different N.g., in an exposed form.
REFERENCES:
patent: 4203971 (1980-05-01), Buchanon
patent: 4220638 (1980-09-01), Karkhonis
patent: 4330623 (1982-05-01), Karkhanis
Terrance G. Cooper, The Tools of Biochemistry, pp. 291-292, (1977).
William A. Pearch and Thomas M. Buchanan, "Attachment Role of Gonococcal Pili," J. Clin. Invest., 61: 931-943, (1978).
Jephcott, et al., "Neisseria Gonorrhoeae III, Demonstration of Presumed Appendages to Cells from Different Colony Types," ACTA Pathol. Microbiol Scand., Section B, 79, 437-439, (1971).
Swanson, et al., "Studies on Gonococcus Infection, I. Pili and Zones of Adhesion: Their Relation to Gonococcal Growth Patterns", Journal of Experimental Medicine, 134, 886-906, (1971).
Buchanan, et al., "Quantitative Determination of Antibody to Gonoccal Pili," Journal of Clinical Investigation, 52, 2896-2909, (1973).
Arko, et al., "Neisseria gonorrhoeae: Effects of Systematic Immunization of Resistance of Chimpanzees to Urethral Infection", Journal of Infectious Diseases, 130 160-164, (1974).
Buchanan, "Antigenic Heterogeneity of Gonococcal Pili," Journal of Experimental Medicine, 141, 1470-1475, (1975).
Buchanan and Pearce, "Pili as a Mediator of the Attachment of Gonococci to Human Erythrocytes", Infection and Immunity, 13, 1483-1489, (1976).
Hermodson, et al., "Neisseria Pili Proteins: Amino-Terminal Amino Acid Sequences and Identification of an Unusual Amino Acid", Biochemistry, 17, 442-445, (1978).
Buchanan, et al., "Pili and Principal Outer Membrane Protein of Neisseria gonorrhoeae: Immunochemical, Structural, and Pathogenic Aspects", Conference Proceedings on Immunobiology of Neisseria Gonorrhoeae, (1978), 145-154, (1978).
Buchanan, et al., "Attachment of Neisseria gonorrhoeae Pili to Human Cells, and Investigations of the Chemical Nature of the Receptor for Gonococcal Pili", Conference Proceedings on Immunobiology of Neisseria Gonorrhoeae, (1978), 242-249, (1978).
Brinton, et al., "Uses of Pili in Gonorrea Control: Role of Bacterial Pili in Disease, Purification and Properties of Gonococcal Pili and Progress in Development of a Gonococcal Pilus Vaccine for Gonorrhea", Conference Proceedings on Immunobiology of Neisseria Gonorrhoeae, (1978), 155-178, (1978).
Pearce and Buchanan, "Optimum Conditions and Quantitation of Adherence of Isolated Pili to Human Cells in Vitro", Journal of Clinical Investigation, 61, 931-943, (1978).
Buchanan, "Prospects and Problems for Development of a Vaccine Against Gonorrhea", Abstract from Embo Workshop on Genetics and Immunobiology of Pathogenic Neisseria, Hemavan, Sweden, (Jun. 1980).
Chen & Buchanan, "Structural Studies of a Gonococcal Pilus", Abstract from Embo Workshop on Genetics and Immunobiology of Pathogenic Neisseria, Hemaven, Sweden (Jun. 1980).
Buchanan Thomas M.
Chen Kirk C. S.
Pearce William
Hazel Blondel
The United States of America as represented by the Department of
LandOfFree
Neisseria gonorrhoeae vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Neisseria gonorrhoeae vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neisseria gonorrhoeae vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-95133